Cite
HARVARD Citation
Stähli, B. et al. (2016). Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial. Journal of the American Heart Association. 5 (11), p. n/a. [Online].